The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 305.00
Bid: 304.30
Ask: 304.50
Change: 1.80 (0.59%)
Spread: 0.20 (0.066%)
Open: 304.90
High: 307.20
Low: 304.00
Prev. Close: 303.20
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

22 Sep 2020 13:21

RNS Number : 7532Z
NatWest Group plc
22 September 2020
 

 

 

September 22, 2020

NATWEST GROUP plc - RESULTS OF TENDER OFFERS FOR CERTAIN OF ITS OUTSTANDING NOTES

 

NatWest Group plc (the "Offeror") is today announcing the final results of its previously announced cash tender offers (each, an "Offer" and, together, the "Offers") for any and all of certain series of its U.S. dollar denominated notes set out in the table below (the "Notes").

The Offers were made on the terms and subject to the conditions set out in the offer to purchase dated September 14, 2020 (the "Offer to Purchase") and the related Notice of Guaranteed Delivery (together, the "Offer Documents"). Capitalized terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

Based on information provided by the Tender Agent, $1,967,908,000 in aggregate principal amount of the Notes were validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on September 21, 2020 (the "Expiration Deadline"), as more fully set forth below. The Offeror has accepted all Notes that were validly tendered and not validly withdrawn prior to the Expiration Deadline. In addition, $9,418,000 in aggregate principal amount of the Notes were tendered using the guaranteed delivery procedures. The Settlement Date is expected to be September 24, 2020.

 

The table below sets forth, among other things, the principal amount of each series of Notes validly tendered and not validly withdrawn at or prior to the Expiration Deadline:

Title of Security

Issuer

ISIN/CUSIP

Principal Amount Outstanding(1)

Aggregate Principal Amount Tendered Excluding Notes Tendered Using Guaranteed Delivery Procedures

 

Aggregate Principal Amount Tendered Using Guaranteed Delivery Procedures

Purchase Price(2)

6.425% Non-Cumulative Trust Preferred Securities ("Trust Securities")

RBS Capital Trust II

US74927PAA75

74927PAA7

$393,573,000(4)

$251,681,000

$4,207,000

$1,556.87

7.648% Dollar Perpetual Regulatory tier One Securities, Series 1 ("PROs")

The Royal Bank of Scotland Group plc(3)

US780097AH44

780097AH4

$761,746,000

$631,491,000

$793,000

$1,547.47

6.125% Subordinated Tier 2 Notes due 2022 ("2022 Notes")

The Royal Bank of Scotland Group plc (3)

US780099CE50

780099CE5

$2,250,000,000

$630,064,000

$2,691,000

$1,098.79

6.100% Subordinated Tier 2 Notes due 2023 ("2023 Notes")

The Royal Bank of Scotland Group plc(3)

US780097AY76

780097AY7

$1,000,000,000

$454,672,000

$1,727,000

$1,116.01

(1) As of the commencement date of the Offers.

(2) Per $1,000 principal amount of the Notes (as defined herein) validly tendered and accepted for purchase.

(3) Currently NatWest Group plc.

(4) Excluding $256,427,000 principal amount of 6.425% Non-Cumulative Trust Preferred Securities, which are held by the Offeror as of the date hereof and are deemed not to be outstanding.

 

 

 

 

FURTHER INFORMATION

 

Lucid Issuer Services Limited acted as tender agent for the Offers. NatWest Markets Securities Inc., an affiliate of the Offeror, acted as Global Arranger and Lead Dealer Manager and Goldman Sachs & Co. LLC and UBS Securities LLC (together with NatWest Markets Securities Inc.) acted as Dealer Managers. Questions regarding the Offers should be directed to NatWest Markets Securities Inc. at +44 20 7678 522, Goldman Sachs & Co. LLC at +1 800 828 3182, +1 212 357-0215 (Collect) or +44 20 7552 6157 (U.K.) and UBS Securities LLC at +1 888 719-4210, + 1 203 719 4210 (Collect) or +44 20 7568 1121 (U.K.).

 

FORWARD-LOOKING STATEMENTS

 

From time to time, we may make statements, both written and oral, regarding our assumptions, projections, expectations, intentions or beliefs about future events. These statements constitute "forward-looking statements". We caution that these statements may and often do vary materially from actual results. Accordingly, we cannot assure you that actual results will not differ materially from those expressed or implied by the forward-looking statements. You should read the sections entitled "Risk Factors" in the Offer to Purchase, in our Annual Report, Q1 2020 Interim Report and H1 2020 Interim Report and "Forward-Looking Statements" in our Annual Report, Q1 2020 Interim Report and H1 2020 Interim Report.

 

Any forward-looking statements made herein or in the documents incorporated by reference herein speak only as of the date they are made. Except as required by the U.K. Financial Conduct Authority (the "FCA"), any applicable stock exchange or any applicable law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in the Offer to Purchase or the documents incorporated by reference herein to reflect any changes in expectations with regard thereto or any new information or any changes in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that we have made or may make in documents we have filed or may file with the SEC.

 

Legal Entity Identifiers

 

NatWest Group plc

2138005O9XJIJN4JPN90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEEAANAAFLEEFA
Date   Source Headline
10th Nov 20223:53 pmRNSDirector/PDMR Shareholding
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
4th Nov 202211:19 amRNSPricing of USD 7.472% Senior Callable Notes
31st Oct 20223:35 pmRNSTotal Voting Rights
28th Oct 20225:52 pmRNSPublication of Suppl.Prospcts
28th Oct 20227:00 amRNSNWG Q3 IMS Interim Management Statement 2022
20th Oct 20229:00 amRNSNatWest and Vodeno Create Strategic Partnership
5th Oct 20221:51 pmRNSBlock listing six monthly return
30th Sep 20222:15 pmRNSDirectorate Change
30th Sep 202212:45 pmRNSTotal Voting Rights
26th Sep 20225:44 pmRNSPublication of Suppl.Prospcts
26th Sep 20223:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20225:25 pmRNSChanges to our Board
23rd Sep 202212:30 pmRNSNatWest Group notes rating actions by Moody's
20th Sep 20229:30 amRNSTR-1: Notification of Major Holdings
20th Sep 20228:00 amRNSBank of America Annual Financials CEO Conference
13th Sep 20228:30 amRNSBarclays Global Financial Services Conference
8th Sep 20222:00 pmRNSDirector/PDMR Shareholding
5th Sep 202211:18 amRNSAdam & Company Private Banking Business
2nd Sep 20222:43 pmRNSPublication of Final Terms - Replacement
2nd Sep 20221:44 pmRNSPublication of Final Terms
31st Aug 20226:23 pmRNSAdjustment to conversion prices for NWG's AT1s
31st Aug 20222:34 pmRNSTotal Voting Rights
30th Aug 20228:10 amRNSShare consolidation and total voting rights
25th Aug 20224:32 pmRNSResult of General Meeting and Class Meeting
25th Aug 20222:00 pmRNSGeneral Meeting and Class Meeting Statement
12th Aug 20222:23 pmRNSUpdate to Financial Impact of Tender Offers
12th Aug 20227:00 amRNSH1 2022 Pillar 3 Supplements
11th Aug 202210:15 amRNSHolding(s) in Company
10th Aug 20226:18 pmRNSFinancial Impact of Tender Offers
10th Aug 20224:30 pmRNSDirector/PDMR Shareholding
9th Aug 20226:26 pmRNSResults of Tender Offers
9th Aug 202211:08 amRNSPricing of Tender Offers
9th Aug 20227:00 amRNSNotice of General Meeting and Class Meeting
1st Aug 20225:02 pmRNSTender Offer
1st Aug 20224:32 pmRNSPublication of Final Terms
29th Jul 20224:59 pmRNSPublication of Supplementary Prospectus
29th Jul 20223:19 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results - NatWest Markets N.V.
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 2 of 2)
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 1 of 2)
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
15th Jul 20226:05 pmRNSTransaction in Own Shares
14th Jul 20225:21 pmRNSTransaction in Own Shares
13th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20225:14 pmRNSTransaction in Own Shares
11th Jul 20225:21 pmRNSTransaction in Own Shares
8th Jul 20225:26 pmRNSTransaction in Own Shares
7th Jul 20225:27 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.